KQ HCPCS Level II modifier: Second or subsequent drug of a multiple drug unit dose formulation
KQ is a HCPCS Level II modifier: “Second or subsequent drug of a multiple drug unit dose formulation.” It adds this detail to the code it is reported with.
Official description
KQSecond or subsequent drug of a multiple drug unit dose formulation
Short description: 2nd/subsqnt drg multi drg ud
HCPCS · United States
Medicare details
The indicators CMS publishes with KQ in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Added
- Apr 1, 1997
Where KQ sits
- 1GroupHCPCS modifiers
- 2Modifier KQSecond or subsequent drug of a multiple drug unit dose formulation
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code KQ mean?
KQ is the HCPCS code for “Second or subsequent drug of a multiple drug unit dose formulation” in CMS’s HCPCS Level II October 2026 release.
Where is KQ in the HCPCS Level II list?
KQ is listed under Modifiers.
Does Medicare cover KQ?
CMS lists KQ’s Medicare coverage as “Carrier judgment”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside KQ
All modifiersKKDmepos item subject to dmepos competitive bidding program number 2KLDmepos item delivered via mailKMReplacement of facial prosthesis including new impression/moulageKNReplacement of facial prosthesis using previous master modelKOSingle drug unit dose formulationKPFirst drug of a multiple drug unit dose formulationKRRental item, billing for partial monthKSGlucose monitor supply for diabetic beneficiary not treated with insulinKTBeneficiary resides in a competitive bidding area and travels outside that competitive bidding area and receives a competitive bid itemKUDmepos item subject to dmepos competitive bidding program number 3KVDmepos item subject to dmepos competitive bidding program that is furnished as part of a professional serviceKWDmepos item subject to dmepos competitive bidding program number 4